{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/urinary-tract-infection-lower-women/management/uti-in-pregnancy-no-visible-haematuria/","result":{"pageContext":{"chapter":{"id":"09df152e-ea9c-51c1-917c-5c4c01ab2fc8","slug":"uti-in-pregnancy-no-visible-haematuria","fullItemName":"Scenario: UTI in pregnancy  no visible haematuria","depth":2,"htmlHeader":"<!-- begin field e39c2e2d-3ba9-40a0-9274-a71b00f2d529 --><h2>Scenario: Suspected urinary tract infection without visible haematuria during pregnancy</h2><!-- end field e39c2e2d-3ba9-40a0-9274-a71b00f2d529 -->","summary":"Covers the management of a suspected UTI during pregnancy in women who do not have visible haematuria.","htmlStringContent":"<!-- begin item 1409566b-e571-4df1-923f-a71b00f2d5ef --><!-- begin field 7a9f614d-e762-4816-b386-acbd0084e67c --><p>From age 16 years onwards (Female).</p><!-- end field 7a9f614d-e762-4816-b386-acbd0084e67c --><!-- end item 1409566b-e571-4df1-923f-a71b00f2d5ef -->","topic":{"id":"4205a2dd-1d74-53f2-90f4-5239307d2883","topicId":"7e36f7cd-e707-44db-a683-f4197a84b187","topicName":"Urinary tract infection (lower) - women","slug":"urinary-tract-infection-lower-women","lastRevised":"Last revised in October 2020","chapters":[{"id":"96f75303-a8ae-50a0-9d5c-e5a9b96e67f1","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"cafb451d-db29-558a-a6cc-20d82dde3df9","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"14a65465-7aa4-5024-bb53-b3b2099b526a","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"7b90ea0f-0f86-5457-965d-930656bd2f02","slug":"changes","fullItemName":"Changes"},{"id":"4f3fd7bc-437b-509c-9a2d-5318de2b1e8b","slug":"update","fullItemName":"Update"}]},{"id":"850e1193-41eb-50b7-b401-ac0396c6e585","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"18c79474-b4ac-50cd-801a-3738d79a1159","slug":"goals","fullItemName":"Goals"},{"id":"24f4bdf7-0aa4-5f6b-a117-2c3a7da00984","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6b590746-634f-5a0c-b995-5f98bd9c6f0d","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4c2be4f2-9e65-53d3-8ff6-7534932e7dc6","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"835cf60d-f7b4-57b8-97ee-607930381034","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"a526f295-371c-52d5-bd46-93333947aade","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"28adde3c-64d3-5e21-8797-08c56ab570c5","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"4a732f85-1f37-5288-a872-611c3528c53e","slug":"definition","fullItemName":"Definition"},{"id":"8e922399-2c9d-5777-9660-944733f631f5","slug":"causes","fullItemName":"Causes"},{"id":"8fa46cfc-d97b-5218-847f-9553a7ce2854","slug":"prevalence","fullItemName":"Prevalence"},{"id":"c9ad7aa8-f54d-55a8-b6f1-804d616de2b4","slug":"prognosis","fullItemName":"Prognosis"},{"id":"a176b8d4-1d8f-5f62-935e-4f6fc4696153","slug":"complications","fullItemName":"Complications"}]},{"id":"03286f6f-e3d8-5889-8453-1db9ffb07914","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"ec9700ef-7ba2-524e-868a-3dc60b345625","slug":"when-to-suspect-uti","fullItemName":"When to suspect UTI"},{"id":"182ae581-d75a-507d-8146-e0d7d26dcad8","slug":"assessment","fullItemName":"Assessment"},{"id":"5dfac6cd-ec1e-5d54-98a4-a65cf57457d9","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"6d45128d-30db-5879-917a-4a6e682fa7e9","fullItemName":"Management","slug":"management","subChapters":[{"id":"a72789b5-d51e-5516-8ab1-942aae1e0fe8","slug":"uti-no-visible-haematuria-not-pregnant-or-catheterized","fullItemName":"Scenario: UTI  (no visible haematuria, not pregnant or catheterized)"},{"id":"91dbd4da-8761-5e78-9eb2-a773cc7d2764","slug":"uti-with-visible-or-non-visible-haematuria","fullItemName":"Scenario: UTI  with visible or non-visible haematuria"},{"id":"3e093a06-3197-58a5-8c61-94586835adba","slug":"recurrent-uti-no-visible-haematuria-not-pregnant-or-catheterized","fullItemName":"Scenario: Recurrent UTI  (no visible haematuria, not pregnant or catheterized)"},{"id":"09df152e-ea9c-51c1-917c-5c4c01ab2fc8","slug":"uti-in-pregnancy-no-visible-haematuria","fullItemName":"Scenario: UTI in pregnancy  no visible haematuria"},{"id":"6d0e09de-6e28-53df-b01b-55fc899c0dd7","slug":"asymptomatic-bacteriuria-in-pregnancy","fullItemName":"Scenario: Asymptomatic bacteriuria in pregnancy"},{"id":"07efc80a-4963-5037-a8f2-c5b63d298205","slug":"uti-with-catheter-no-haematuria","fullItemName":"Scenario: UTI with catheter  no haematuria"}]},{"id":"7a32c4da-f7b1-5664-92e2-e1fdeca6361a","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"b42d0bbc-d0ac-52c7-83bf-5fc7a76a38dc","slug":"trimethoprim","fullItemName":"Trimethoprim"},{"id":"76a10025-1806-5d3b-96b0-72401241a768","slug":"nitrofurantoin","fullItemName":"Nitrofurantoin"},{"id":"625120b5-8124-549f-b13c-8b37bea158ff","slug":"pivmecillinam","fullItemName":"Pivmecillinam"},{"id":"bae5a7ea-ae42-56ba-82cc-74cbc655059f","slug":"fosfomycin","fullItemName":"Fosfomycin"},{"id":"e8dc8860-ec55-59c6-96c0-805260cb7172","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"e5121975-a684-5651-bf41-c324e815c0f5","slug":"cefalexin","fullItemName":"Cefalexin"}]},{"id":"332fba52-4a32-56f0-b721-29ac73f73e6d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"8f34f8fc-4bd2-54e3-87f0-a4a1394f3891","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"9b392302-d709-5520-a890-25e10021e12b","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0d4bbe1a-f3f6-523c-85c0-1fae02dd5b27","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"84ca6e0f-7674-5f70-b099-406d5c783d89","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"4ed139aa-715a-523d-8c0a-8f4e167d29df","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"067e363b-53be-5584-a0e9-2bf38e519877","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"045ecabb-df97-5df3-b561-ecddea4b7b17","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"6d45128d-30db-5879-917a-4a6e682fa7e9","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"23bfe3ac-3ecd-57bb-a598-3094c59448bb","slug":"management","fullItemName":"Management","depth":3,"htmlHeader":"<!-- begin field 18ca526a-a028-47bc-a15f-a71b00fe842d --><h3>How should I manage women with suspected urinary tract infection without haematuria in pregnancy?</h3><!-- end field 18ca526a-a028-47bc-a15f-a71b00fe842d -->","summary":null,"htmlStringContent":"<!-- begin item a848870d-8d9f-453c-8121-a71b00fe84f1 --><!-- begin field d08e1449-30aa-4921-b7fb-a71b00fe842d --><ul><li><strong>Arrange urgent assessment in secondary care</strong> if there are any features of serious or systemic illness such as sepsis or pyelonephritis.<ul><li>For further information on pyelonephritis, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/pyelonephritis-acute/\">Pyelonephritis - acute</a>.</li></ul></li><li><strong>Seek urgent specialist advice on further management of pregnant women:</strong><ul><li>With recurrent lower UTI.</li><li>With catheter associated UTI.</li><li>If culture reveals an atypical bacteria.</li><li>With an underlying structural or functional abnormality or co-morbidity which increases the risk of complications or treatment failure.</li><li>With suspected underlying malignancy or renal disease.</li></ul></li><li><strong>For uncomplicated first lower UTI in a pregnant woman </strong><ul><li><strong>Give advice on self-care measures:</strong><ul><li>Simple analgesia such as paracetamol can be used for pain relief — for further information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a><u>.</u></li><li>Encourage intake of enough fluids to avoid dehydration.</li><li>A patient information leaflet ‘<a data-hyperlink-id=\"2b1778fc-5486-4578-86ee-a9e400e98fdb\" href=\"https://www.rcgp.org.uk/clinical-and-research/resources/toolkits/target-antibiotic-toolkit.aspx\" target=\"_blank\">Treating your infection – Urinary tract infection (UTI)</a>’ is available from the <a data-hyperlink-id=\"a2261cd3-79a3-4bdf-82bd-a9e400e99045\" href=\"https://www.rcgp.org.uk/\" target=\"_blank\">Royal Collage of General Practice website</a>.</li></ul></li><li><strong>Send a midstream urine sample</strong> for culture and sensitivities before antibiotics are taken.</li><li><strong>Offer an immediate antibiotic prescription</strong> taking account of previous urine culture and susceptibility results, previous antibiotic use (which may have led to resistant bacteria) and local resistance patterns – if unsure discuss with a specialist:</li><li>As first choice antibiotic consider prescribing:<ul><li>Nitrofurantoin (<em>avoid at term</em>) 100mg modified-release twice a day for 7 days if eGFR ≥45ml/minute.</li></ul></li><li>As second-choice (no improvement in lower UTI symptoms on first-choice taken for at least 48 hours or when first-choice not suitable) consider prescribing:<ul><li>Amoxicillin (only if culture results available and susceptible) 500mg three times a day for 7 days.</li><li>Cefalexin 500mg twice a day for 7 days.</li><li>For alternative second-choices discuss with local microbiologist.</li></ul></li><li>A summary of the National Institute for Health and Care (NICE) <a data-hyperlink-id=\"ac039ee9-e78b-40f9-be11-a9e400e7c387\" href=\"https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/antimicrobial-prescribing-guidelines\">antimicrobial prescribing guidance</a> is available on the <a data-hyperlink-id=\"d5362765-609a-414e-b696-a9e400e7c39d\" href=\"http://www.nice.org.uk/\" target=\"_blank\">NICE website</a>.</li></ul></li><li><strong>Advise the woman to seek urgent review if:</strong><ul><li>Symptoms worsen at any time or fail to improve within 48 hours of starting antibiotics — consider the possibility of <a class=\"topic-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/diagnosis/differential-diagnosis/\">alternative or serious diagnoses</a> such as pyelonephritis or sepsis.<ul><li>Discuss ongoing management with a specialist — treatment with another agent (as described above) may be appropriate while awaiting sensitivities.</li></ul></li></ul></li><li><strong>Follow up</strong><ul><li>Review choice of antibiotic when results are available.</li><li>Change the antibiotic according to susceptibility results if bacteria are resistant — use narrow-spectrum antibiotics if possible and seek specialist advice if unsure.</li><li>Send urine for culture once treatment is completed to ensure clearance of infection.</li></ul></li></ul><!-- end field d08e1449-30aa-4921-b7fb-a71b00fe842d --><!-- end item a848870d-8d9f-453c-8121-a71b00fe84f1 -->","subChapters":[{"id":"a2931186-f646-50be-a0d7-cf2390e55317","slug":"basis-for-recommendation-bc5","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field ce415eb9-5824-4c6f-a991-a71b00fe8432 --><h4>Basis for recommendation</h4><!-- end field ce415eb9-5824-4c6f-a991-a71b00fe8432 -->","summary":null,"htmlStringContent":"<!-- begin item bc55a2f0-869b-42db-bb85-a71b00fe8432 --><!-- begin field 05287815-79eb-4eb0-9d8b-a71b00fe8432 --><p>The recommendations on the management of UTI in pregnancy are based on the clinical guidelines <em>Diagnosis of urinary tract infections (UTIs). Quick reference guide for primary care: for consultation and local adaptation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>], Urinary tract infections (lower): antimicrobial prescribing [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018d</a>], <em>Urological Infections  </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">EAU, 2018</a>], <em>Recurrent urinary tract infections: antimicrobial prescribing</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018b</a>]<em>, Catheter associated urinary tract infections: antimicrobial prescribing</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018c</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Schneeberger, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Johnston, 2017</a>].</p><h5>Arrange urgent assessment</h5><p>Clinical guidelines from Public Health England (PHE) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>] and the National Institute for Health and Care Excellence (NICE) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018d</a>] highlight the importance of prompt recognition and treatment of serious illness such as pyelonephritis and sepsis.</p><h5>Seek specialist advice</h5><p>The recommendations on when to seek specialist advice are based on the NICE guidelines <em>Urinary tract infections (lower): antimicrobial prescribing</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018d</a>], <em>Recurrent urinary tract infections: antimicrobial prescribing</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018b</a>] and <em>Catheter associated urinary tract infections: antimicrobial prescribing</em>  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018c</a>] and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Johnston, 2017</a>].</p><ul><li>Recurrent UTI in pregnancy can lead to serious adverse pregnancy outcomes for both mother and child including pyelonephritis, preterm birth and small‐for‐gestational‐age babies [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Schneeberger, 2015</a>].</li><li><em>Escherichia coli</em> is the most common organism identified in UTI in pregnancy. UTI caused by an atypical bacteria (such as Proteus or Klebsiella species) may indicate underlying pathology such as urinary tract calculi which requires further investigation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Johnston, 2017</a>].</li></ul><h5>Self-care measures</h5><p>The recommendations on self-care measures are based on clinical guidelines from PHE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>] and NICE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018d</a>].</p><h5>Treatment of uncomplicated UTI in pregnancy</h5><p>The recommendations on treatment of uncomplicated UTI in pregnancy are based on clinical guidelines from PHE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>], EAU [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">EAU, 2018</a>] and NICE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018d</a>].</p><ul><li>Guidance is in agreement that pregnant women with UTI be offered an immediate antibiotic to prevent complications such as pyelonephritis.</li><li>A urine sample should be sent before antibiotics are taken to ensure appropriate antimicrobial therapy has been prescribed [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>].</li></ul><h5>Antibiotic choice and course length</h5><p>Recommendations on antibiotic choice for UTI in pregnancy are taken from the NICE guideline <em>Urinary tract infections (lower): antimicrobial prescribing</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018d</a>].</p><ul><li>When prescribing, local resistance patterns, previous urine culture and susceptibility results and previous antibiotic use (which may have led to resistant bacteria) should be taken into account [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Johnston, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">EAU, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018d</a>].</li><li>A 7-day course of antibiotic therapy is recommended by the NICE guideline committee (based on evidence and clinical experience) to ensure complete cure as the risk of harm from a UTI is higher in pregnant women than in non-pregnant women [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018d</a>].</li></ul><h5>Advise review if symptoms worsen or do not improve</h5><p>Guidance from PHE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>] and NICE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018d</a>] recommends that women are advised to seek urgent medical review if symptoms worsen at any time or fail to improve within 48 hours of starting antibiotics.</p><ul><li>The possibility of alternative and serious diagnoses such as pyelonephritis or sepsis should be considered.</li></ul><h5>Follow up</h5><ul><li>Guidance from NICE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018d</a>] recommends review of choice of antibiotic when microbiological results are available and prescription of an alternative according to susceptibility if bacteria are resistant.</li><li>Guidance from PHE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>] recommends sending a urine for culture and sensitivities once treatment is completed to ensure clearance of infection.</li></ul><!-- end field 05287815-79eb-4eb0-9d8b-a71b00fe8432 --><!-- end item bc55a2f0-869b-42db-bb85-a71b00fe8432 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}